Chinese contract research organisation (CRO) SAFE Pharmaceutical Technology has snapped up 500 million yuan ($71.8 million) in a Series D round led by two state-owned investors including SDIC Venture Capital and China Reform Holdings.
Continue reading with Data Vantage
Venture-backed company data in SE Asia, India, Pakistan, Bangladesh.
Instant investment updates and valuations.
Tailored search, 3 monthly reports.
Industry-trusted platform.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
